Epitalon vs Rapamycin for longevity
Short answer: For longevity, users rate them about the same: 100% report improvement with Epitalon (27 reports) and 100% with Rapamycin (7 reports).
Epitalon has 0 meta-analyses and 0 randomized trials on PubMed; Rapamycin has 497 and 1,245.
Based on 235 reports about Epitalon and 61 about Rapamycin. Not medical advice.
| Epitalon Peptide | Rapamycin Medication | |
|---|---|---|
| Users say it helped | 68%helped80 reports · medium confidence | 28%helped11 reports · few reports |
| Verdict | Mostly positive | Mixed |
| Research | DResearch: None | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 0 | 497 / 1,245 |
| Mainly used for | ||
| Sleep % reporting improvement | 83% (59) | — |
| Longevity % reporting improvement | 100% (27) | 100% (7) |
| Skin & hair % reporting improvement | 93% (14) | — |
| Mood % reporting improvement | 75% (12) | 100% (2) |
| Energy % reporting improvement | 90% (10) | — |
| Common side effects | vivid dreams, drowsiness, grouchiness, eye muscle | fatigue, slow wound, canker sores, hyperglycemia |
| Typical dose reported | Not listed | Not listed |
“Epitalon: Added this recently at the end of my cycles for the telomere/anti-aging benefits. The unexpected perk? It totally reset my circadian rhythm, amplifying the sleep stack even more.”
The majority of the patients reported adverse events limited to grade 1 or 2. On the whole, the data presented herein confirm the findings of previous studies on the relative safety of everolimus, a targeted therapeutic agent, which differs from that of conventional chemotherapy, and highlight the potential adverse events associated with the therapeutic use of everolimus.
Int J Oncol, 2021 ↗“I've noticed a 10% increase in HDL and some fatigue the day after taking more than 6mg.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate